SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Regulatory & Safety

Read more breaking news

 

 
News in brief

Strides Arcolab wins FDA approval for India facility

28-Apr-2014

Strides Arcolab announced Friday that its oral dosage manufacturing site in Bangalore, India, was recently approved by the US FDA following a GMP compliance audit. 

The last FDA inspection and approval of the facility -- which manufactures oral dosage forms such as tablets, capsules and sachet -- was in 2011. Strides has four other facilities with which it provides treatments for more than 75 countries.

The approval comes as Strides is still dealing with a Form 483 the company received from the FDA back in August for its injectables facility.

That letter cited the company’s insufficient response to corrective actions, as well as its failure to establish an appropriate monitoring system of environmental conditions. 

Related products

Key Industry Events

 

Access all events listing

Our events, Events from partners...

Products

Solid Lipid Excipients: Born to be Extruded !
Gattefossé Pharma
USP<233> Elemental Impurities Sample Prep Strategy
SGS Life Science Services
Online Cell Density Monitoring
Hamilton Bonaduz AG
Residual moisture in lyophilized pharmaceuticals
Metrohm – customized analysis for the pharmaceutical industry
Need help to bring insoluble APIs to the market?
Dow Pharma & Food Solutions